Ganzhou Hemay Pharmaceutical Co., Ltd

This is an early-stage study testing a new drug called Hemay181 in patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to see if the drug is safe and if it can shrink tumors. The study will enroll about 24 patients who have …

This early-stage study aims to understand how a potential psoriasis drug, Hemay005, is processed by the body in people with mild or moderate liver impairment compared to those with normal liver function. It involves 24 participants who will take a single dose. The main goal is to…